Envista Corp
NVST | NYSE
$23.43
+$0.08 (+0.34%)
At close: Sep 21, 2026, 4:00 PM ET
$23.12
-$0.31 (-1.32%)
Pre-market:
Sep 22, 2026, 4:20 AM ET
Company Profile
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.
Key Executives
| Name | Position |
|---|---|
| Paul A. Keel | President, CEO & Chairman |
| Andrew Chen | Chief Information Officer |
| Eric D. Hammes | Senior Vice President & Chief Financial Officer |
| Coree Thomas | VP & Chief Accounting Officer |
| Faez Kaabi | Vice President, Chief Accounting Officer & Corporate Controller |
| Jim Gustafson | Vice President of Investor Relations |
| Mark E. Nance | Senior Vice President, General Counsel & Secretary |
| Mischa Reis | Senior Vice President of Strategy & Corporate Development |
| Paul Sumilas | Chief Compliance Officer |
| Robert Befidi Jr. | Senior VP & President of Diagnostics |
| Suraj Satpathy | Chief Human Resources officer |
| Veronica Acurio | Senior Vice President & President of Orthodontics |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 27, 2026 | 4 | Filing |
| Aug 27, 2026 | 4 | Filing |
| Aug 27, 2026 | 4 | Filing |
| Aug 27, 2026 | 4 | Filing |
| Aug 24, 2026 | 4 | Filing |
| Aug 20, 2026 | 4 | Filing |
| Aug 20, 2026 | 4 | Filing |
| Aug 19, 2026 | 8-K | Current Report |
| Aug 13, 2026 | 3 | Filing |
| Aug 05, 2026 | 10-Q | Quarterly Report |
Envista Corp
| Country | United States |
| IPO Date | Sep 17, 2019 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 12,000 |
| CEO | Paul A. Keel |
Contact Details
Building E Brea,
California 92821-6208 United States
Stock Details
| Ticker Symbol | NVST |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001757073 |
| CUSIP Number | 29415F104 |
| ISIN Number | US29415F1049 |
| SIC Code | 3843 |
Recent News
- 3 days ago / zacks.comShould Value Investors Buy Envista (NVST) Stock?
- 3 days ago / zacks.comDown 12% in 4 Weeks, Here's Why You Should You Buy the Dip in Envista (NVST)
- 4 days ago / seekingalpha.comEnvista Holdings Corporation (NVST) Analyst/Investor Day Transcript
- 4 days ago / zacks.comHere's Why Envista (NVST) is a Strong Value Stock
- 6 days ago / seekingalpha.comEnvista Holdings Corporation (NVST) Presents at 2026 Global Healthcare Conference Transcript
- 13 days ago / zacks.comNVST or ABT: Which Is the Better Value Stock Right Now?
- 14 days ago / prnewswire.comEnvista Announces Participation in Baird 2026 Global Healthcare Conference
- 18 days ago / zacks.comEnvista (NVST) Up 0.8% Since Last Earnings Report: Can It Continue?
- 26 days ago / zacks.comBest Momentum Stocks to Buy for August 27th
- 28 days ago / zacks.comWhy Envista (NVST) is a Top Value Stock for the Long-Term
Add to Watchlist
Select watchlists to add or remove NVST